window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 15, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Women in Pharma

Women in PharmaDebbie2026-02-23T12:09:55+00:00
  • Clinical Development,Clinical Trials,Data Management,Global health,Real world evidence

    Phesi data highlights 6.7% of global clinical trials affected by Middle East disruption

    New analysis from Phesi suggests 6.7% of globally recruiting clinical [...]

    read more
  • Healthcare leadership,Mergers & Acquisitions,Movers & Shakers,Pharmaceuticals and therapeutics

    Genmab appoints Margarida Duarte as general manager for Europe and emerging markets

    Genmab has appointed Margarida Duarte as general manager, Europe and [...]

    read more
  • Healthcare leadership,Market Access & Commercialization,Movers & Shakers,Pharmaceuticals and therapeutics,Startups and innovations

    Opella appoints former Reckitt executive Gonzalo Balcazar to lead Europe and Latin America

    Opella has appointed Gonzalo Balcazar as president of Europe and [...]

    read more
  • Biotech,Healthcare leadership,Movers & Shakers,Oncology,Pharmaceuticals and therapeutics,Research & Development

    Orano Med appoints Frederic Desdouits as CEO to advance targeted alpha therapy pipeline

    Orano has appointed Frederic Desdouits as chief executive officer of [...]

    read more
  • Biotech,Clinical Development,Clinical Trials,Healthcare leadership,Immunology,Movers & Shakers

    Aravax adds allergy specialists to board as peanut therapy advances

    Aravax has appointed two senior industry figures to its board [...]

    read more
  • Artificial Intelligence,Clinical studies,Drug discovery,Neurosciences,Pharmaceuticals and therapeutics

    AI-derived drug candidate reduces fentanyl intake in preclinical opioid study

    A study published in Proceedings of the National Academy of [...]

    read more
  • Clinical Development,Neurosciences,Partnerships & Funding,Research & Development

    SonoNeu exits stealth as part of $41.3M ARPA-H programme to advance sonogenetics

    SonoNeu has emerged from stealth as part of a $41.3m [...]

    read more
  • Clinical Development,Neurosciences,Partnerships & Funding,Research & Development

    AC Immune amends Lilly collaboration on Tau small molecules for Alzheimer’s disease

    AC Immune has amended its collaboration agreement with Eli Lilly [...]

    read more
  • Biologics & Biosimilars,Clinical Trials,Manufacturing,Oncology,Research & Development

    Anixa Biosciences advances breast cancer vaccine toward Phase 2 with Cytovance manufacturing deal

    Anixa Biosciences is advancing its breast cancer vaccine programme towards [...]

    read more
  • Cardiovascular diseases,Clinical Trials,Rare Diseases,Regulatory Affairs,Research & Development

    Cereno Scientific reports long-term safety data from CS1 pulmonary arterial hypertension program

    Cereno Scientific has reported initial long-term safety findings from a [...]

    read more
Previous234Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Virica and Fujifilm target AAV manufacturing bottleneck with enhancer collaboration
    Categories: Biomanufacturing, Cell & Gene Therapy, Drug Development, Manufacturing, Partnerships & Funding
  • Allucent adds strategy leaders to expand therapeutic expertise
    Categories: Clinical Development, Drug Development, Healthcare leadership, Movers & Shakers, Neurosciences, Oncology, Rare Diseases
  • Circio raises NOK 250M in oversubscribed private placement to advance circRNA gene therapy platform
    Categories: Biotech, Funding, Genetic Diseases, Mergers & Acquisitions, Research & Development, RNA Therapeutics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top